首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)
Authors:Philippe Bourin  Bruce A Bunnell  Louis Casteilla  Massimo Dominici  Adam J Katz  Keith L March  Heinz Redl  J Peter Rubin  Kotaro Yoshimura  Jeffrey M Gimble
Institution:1. Department of Hematology and Medical Oncology, Winship Cancer Institute, and Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA;2. Section of Hematology, Stem Cell Research Laboratory and Cell Factory, Department of Medicine, University of Verona, Verona, Italy;3. Stem Cell Allotransplantation Section, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA;4. Regenerative and Heamatological Medicine, King''s College London, London, UK;5. Regenerative Medicine, Athersys Inc., Cleveland, OH, USA;6. School of Engineering and Materials Science, Queen Mary University of London, London, UK;7. Department of Medical and Surgical Sciences for Children and Adults, Division of Oncology, University-Hospital of Modena and Reggio Emilia, Modena, Italy;8. Department of Immunohematology and Bloodtransfusion, Leiden University Medical Centre, Leiden, Netherlands;9. Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children''s Hospital, Houston, TX, USA;10. Center for Stem Cell Research and Regenerative Medicine, Department of Medicine, and Department of Surgery, Tulane University School of Medicine, New Orleans, LA, USA;11. Department of Medicine, University of Wisconsin—Madison, School of Medicine and Public Health, and University of Wisconsin Carbone Cancer Center, Madison, WI, USA;12. Department of Haematology, St George''s Hospital and Medical School, London, UK;13. Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Stockholm, Sweden;14. Department of Biomedicine, University Hospital Basel, Basel, Switzerland;15. Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;16. Mesoblast Inc., New York, NY, USA;17. Stem Cell Group, Bioprocessing Technology Institute, Agency for Science Technology and Research (A*STAR), Singapore;18. Division of Occupational and Environmental Health Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA;19. Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, FL, USA;20. IFR150 STROMALab UMR 5273 UPS–CNRS–EFS–INSERM U1031, Toulouse, France;21. Institute of Health Sciences, Chinese Academy of Sciences, Shanghai, China;22. Cell Processing Section, Department of Transfusion Medicine Clinical Center, NIH, Bethesda, MD, USA;23. Cell Therapy Program, University Health Network, Toronto, Canada;24. Department of Medicine, University of Vermont College of Medicine, Burlington, VT, USA;25. UMR5273 STROMALab CNRS/EFS/UPS—INSERM U1031, Toulouse, France;26. Blood Services Group, Health Sciences Authority, Singapore;27. The First Affiliated Hospital, Soochow University Institutes for Translational Medicine, Suzhou, China
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号